Contents

Current Cancer Drug Targets, Volume 16 - Number 1

Meet Our Editorial Board Member:

, 16(1): 1

Jianwei Zhou


DOI: 10.2174/156800961601151218113139




MYC as Therapeutic Target for Embryonal Tumors: Potential and Challenges

, 16(1): 2 - 21

Tarek Shalaby and Michael A. Grotzer


DOI: 10.2174/1568009615666150916092745




T Cell Redirecting Therapies for Cancer Treatment

, 16(1): 22 - 33

Barbra Sasu and Javier Chaparro-Riggers


DOI: 10.2174/1568009615666150827093149





Extracellular Vesicles as Novel Delivery Tools for Cancer Treatment

, 16(1): 34 - 42

Erdogan Pekcan Erkan and Okay Saydam


DOI: 10.2174/1568009615666150923115439





Electrochemotherapy as First Line Cancer Treatment: Experiences from Veterinary Medicine in Developing Novel Protocols

, 16(1): 43 - 52

E. P. Spugnini, T. Azzarito, S. Fais, M. Fanciulli and A. Baldi


DOI: 10.2174/156800961601151218155340




Molecular Genetics and Targeted Therapy in Hepatocellular Carcinoma

, 16(1): 53 - 70

Eric I. Marks and Nelson S. Yee


DOI: 10.2174/1568009615666150916092903





Cytochrome P450 2W1 (CYP2W1) in Colorectal Cancers

, 16(1): 71 - 78

Felicia Fei-Lei Chung, Chun Wai Mai, Pei Yuen Ng and Chee-Onn Leong


DOI: 10.2174/1568009616888151112095948





Identification of Drug Targets in Helicobacter pylori by in silico Analysis : Possible Therapeutic Implications for Gastric cancer

, 16(1): 79 - 98

Deepthi Nammi, Ravi C. P. K. Srimath-Tirumala-Peddinti and Nageswara Rao R. Neelapu


DOI: 10.2174/1568009615666150602143239





Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science